
As part of the Startup Camps powered by Innosuisse, Swissnex is bringing a cohort of Swiss startups to NY Tech Week 2026, one of the world’s largest and most vibrant decentralized tech gatherings. This year, seven Swiss founders are in town for the week, and together with the ETH and EPFL Alumni Chapters in New York, we’re showcasing their startups and celebrating Swiss innovation in the tech space.
Each founder will share more about their startup and what they’re building, followed by an evening of networking. The cohort spans deep tech, fintech, wealthtech, life sciences AI, and techbio, including ETH spin-offs UNOMR, doing pioneering work in single-molecule protein analysis, and TALPA-Inspection, developing autonomous drones for infrastructure monitoring. Some are early-stage, some are already generating revenue and entering the US market. All of them are here for the week and looking forward to connecting.
Program
- 6:00pm – Doors open
- 6:30pm – Welcome remarks by Swissnex, ETH Alumni NYC & EPFL Alumni NYC
- 6:35pm – Swiss startup pitches (7 x 2 min)
- 6:50pm – Networking
- 9:00pm – End
iCal / Outlook
Event start time
-
New York
6:00PM
Startups
-
![]()
Fintech / Edtech
eFrontiers
Fintech / EdtechUS market entry for fintech; accepted into NXTUS program; $400K raised
-
![]()
Fintech
Happy Pot
FintechDigital collective payments platform; bootstrapped with organic US traction
-
![]()
Life Sciences AI
APXORA
Life Sciences AIAI SaaS for life sciences workflows; revenue-generating institutional pilots
-
![]()
Deep Tech
TALPA-Inspection
Deep TechAutonomous drone infrastructure monitoring; pre-seed live, paid pilots
-
![]()
Wealthtech
Yainvest
WealthtechAI-driven investment intelligence for asset managers; quantitative focus
-
![]()
Sportstech
Automadic
Sportstech3D virtual modeling platform for sports venues; organic traction with NBA, NFL, NHL
-
![]()
TechBio / Deep Tech
UNOMR
TechBio / Deep TechETH Zurich spin-off pioneering single-molecule protein analysis via patented nanopore sensor; applications in pharma R&D, diagnostics, and precision medicine. Venture Kick-backed.






